Cannabis
Parallel’s goodblend™ Texas Launches the First CBN Cannabis Product Line for Patients Through Texas Compassionate Use Program
goodblend™ Texas, a retail brand of Parallel, one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabinol (CBN) products for patients registered in the Texas Compassionate Use Program. The Surterra Wellness Dream +CBN branded tincture introduction marks the fifth first-to-market product innovation the company has launched in the Lone Star State in the last nine months, following the launch of Texas’ first medical cannabis capsule format for qualifying patients. Earlier this week, Parallel’s Massachusetts retail brand, New England Treatment Access (NETA), launched a Surterra Wellness Dream +CBN product, making it the first CBN product offered to its customers.
“We are excited to debut yet another first-to-market cannabis product in Texas and to extend our Surterra Wellness line into the Massachusetts market with the launch of Dream +CBN. Our proprietary formulas are crafted to help qualifying patients improve their quality of sleep, which is a big contributor to overall health and well-being,” said William “Beau” Wrigley, Jr., Chief Executive Officer and Chairman of Parallel. “Dream +CBN exemplifies Parallel’s emphasis on bringing patients a wide variety of innovative product formats and proprietary cannabinoid blends through our dedicated R&D team.”
In Texas, the Dream +CBN product line comes in a 15mg dose of CBN and THC per milliliter (ml), contains a proprietary Dream terpene profile, and is infused with the cannabinoid ratio of 2 CBN : 1 THC.
“goodblend Texas is proud to be the first medical cannabis dispensary in Texas to offer a product with the rare cannabinoid CBN to qualifying patients across the Lone Star State through the Compassionate Use Program. Good quality sleep is essential to overall health and well-being, and we are excited to provide qualifying patients a high-quality alternative to sleep aids to help them feel rested and restored,” said Marcus Ruark, President of goodblend Texas.
Medical cannabis patients across Texas already registered in the program, and those interested in learning more about cannabis, can access board-certified prescribers, medical cannabis information, services, and products in the following ways:
- The goodblend Virtual Clinic is a service in which prospective patients can schedule consultations with a board-certified prescriber through a seamless experience. To get started, visit tx.goodblend.com/clinic.
- goodblend.com offers a wide variety of products, easy online ordering, and free contactless home delivery, often in as little as three days.
- goodblend’s partner clinics in Plano, Houston, Fort Worth, and San Antonio provide registered patients a convenient way to pick up goodblend cannabis products at locations in major metropolitan areas.
The launch of the first CBN product in Texas follows the recent news that Parallel invested $25M in a new state-of-the-art cannabis cultivation, production, and retail facility in San Marcos, Texas. This financial commitment expands Parallel’s ability to meet the growing demand for medical cannabis products in Texas. The planned 63,000 square-foot facility is expected to create hundreds of new jobs in the San Marcos region over the coming years. The company also recently introduced its goodblend™ retail brand, which reflects Parallel’s intent to lead the way to the future of cannabis by providing patients a trusted, consistent and seamless way to connect and learn, and to access innovative, high-quality cannabis products in a variety of formulations. The brand is about welcoming every type of customer and being an approachable source for customers’ well-being.
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
Cannabis
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
StickIt2 weeks ago
StickIt Technologies Inc. Announces Year-End 2023 Financial Results
-
Cannabis1 week ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
Cannabis1 week ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis2 weeks ago
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis1 week ago
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis1 week ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services
-
Cannabis2 weeks ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
transfer4 days ago
IMC to transfer its Oranim Pharmacy shares back to the seller